Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03867149
Other study ID # RC31/18/0337
Secondary ID IDRCB
Status Recruiting
Phase N/A
First received
Last updated
Start date May 14, 2019
Est. completion date April 2023

Study information

Verified date January 2020
Source University Hospital, Toulouse
Contact Jérémie PARIENTE, MD, PHD
Phone 05 61 77 76 86
Email jeremie.pariente@inserm.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to expand evidence about the importance of the mediodorsal nucleus of the thalamus as a key node in human higher-order cognitive functions such as learning, decision-making, and adaptive behavior. Thus, the project proposes to assess global cognition along with higher-order cognition integrity via sensitive behavior tasks in patients with well localized lesions (mediodorsal thalamic infarcts) compared with healthy participants.


Description:

The recruitment of patients with isolated thalamic lesion after stroke is known to be a challenge that the investigators overcame through the expertise of neurologists within their stroke unit.

First, they will describe the cognitive profile consecutive to a lesion of the thalamus, assessed with standardized neuropsychological tests.

Second, and more specifically, they will study performances at experimental tasks focusing on higher-order cognition (decision-making, updating, interference managing, multitasking).

They will use the automatic localization method already performed : the lesions will be manually segmented from T1 morphologic sequences, and then normalized in a template. Finally a numerical atlas of thalamus will be applied on the lesions, determining the injured substructure and the lesion volume.

Besides, this method will be compared with new high resolution thalamus-centered anatomical sequences allowing direct and individual identification of the involved thalamic nucleus.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date April 2023
Est. primary completion date April 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion criteria for patients:

- French as their mother tongue

- Absence of cognitive deterioration before the stroke.

- Visual, auditory (equipment authorized) and oral or written skills sufficient for the proper assessment using neuropsychological tests.

- First infarct affecting the thalamus.

- At least seven years' schooling from primary school

- Signed informed consent

- Chronic lesion (> 3 months)

Inclusion criteria for controls:

- French as their mother tongue

- Absence of cognitive complain

- Visual, auditory (equipment authorized) and oral or written skills sufficient for the proper assessment using neuropsychological tests.

- At least seven years of school from primary school

- Signed informed consent

Exclusion criteria for patients:

- Neurological deficit or significant residual disability at inclusion.

- Aphasia, agnosia, apraxia or severe neglect, as demonstrated by clinical examination and neuropsychological tests.

- Subjects with a contraindication to MRI.

- General, neurological or psychiatric progressive disease.

Exclusion criteria for controls:

- Subjects with a contraindication to MRI.

- General, neurological or psychiatric progressive disease.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
neuroimaging
neuroimaging including high-resolution imaging of the thalamus, DTI and resting state fMRI
Neuropsychological assessment
neuropsychological assessment of memory, language, executive functions and mood

Locations

Country Name City State
France Hopital Purpan - CHU de Toulouse Toulouse

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Toulouse Institut National de la Santé Et de la Recherche Médicale, France

Country where clinical trial is conducted

France, 

References & Publications (4)

Cipolotti L, Husain M, Crinion J, Bird CM, Khan SS, Losseff N, Howard RS, Leff AP. The role of the thalamus in amnesia: a tractography, high-resolution MRI and neuropsychological study. Neuropsychologia. 2008 Sep;46(11):2745-58. doi: 10.1016/j.neuropsychologia.2008.05.009. Epub 2008 May 21. — View Citation

Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J. Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus. Neurology. 2015 Dec 15;85(24):2107-15. doi: 10.1212/WNL.0000000000002226. Epub 2015 Nov 13. — View Citation

Kopelman MD. What does a comparison of the alcoholic Korsakoff syndrome and thalamic infarction tell us about thalamic amnesia? Neurosci Biobehav Rev. 2015 Jul;54:46-56. doi: 10.1016/j.neubiorev.2014.08.014. Epub 2014 Sep 16. Review. — View Citation

Pergola G, Güntürkün O, Koch B, Schwarz M, Daum I, Suchan B. Recall deficits in stroke patients with thalamic lesions covary with damage to the parvocellular mediodorsal nucleus of the thalamus. Neuropsychologia. 2012 Aug;50(10):2477-91. doi: 10.1016/j.neuropsychologia.2012.06.019. Epub 2012 Jun 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Performance at the SET (Six Elements Test) Performances of patients with a mediodorsal thalamic infarct in tasks assessing higher order cognition compared to healthy participants. Assessment of multitasking : 6 sub-tasks have to be achieved within 15 minutes.
They include arithmetic tasks, image naming tasks, and dictation of a known route.
Quantitative scores are derived from quantitative et qualitative data, then interpreted with international normative values.
Day 1
Secondary Performances at the PASAT (Pace Auditory Serial Addition Test) updating during working memory Performances of patients with a mediodorsal thalamic infarct in sensitive executive tests compared to healthy participants.The PASAT assesses the updating during working memory. Day 1
Secondary Performances at the Brown-Petterson task Performances of patients with a mediodorsal thalamic infarct in sensitive executive tests compared to healthy participants. The Brown-Petterson task focuses on the management of interference during working memory. Day 1
See also
  Status Clinical Trial Phase
Completed NCT04921683 - The Use of LIFUP in Chronic Disorders of Consciousness N/A